Nizatidine
Nizatidine is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand name including Nizatidine. Available dosage forms: capsule, powder.
Drug Details
- Generic Name
- Nizatidine
- Brand Names
- Nizatidine
- Application Number
- ANDA077314
- Sponsor
- Dr Reddy's Laboratories Limited
- NDC Codes
- 10
- Dosage Forms
- CAPSULE, POWDER
- Routes
- ORAL
- Active Ingredients
- NIZATIDINE
Indications and Usage
INDICATIONS AND USAGE Nizatidine is indicated for up to 8 weeks for the treatment of active duodenal ulcer. In most patients, the ulcer will heal within 4 weeks. Nizatidine is indicated for maintenance therapy for duodenal ulcer patients, at a reduced dosage of 150 mg h.s. after healing of an active duodenal ulcer. The consequences of continuous therapy with nizatidine for longer than 1 year are not known. Nizatidine is indicated for up to 12 weeks for the treatment of endoscopically diagnosed esophagitis, including erosive and ulcerative esophagitis, and associated heartburn due to GERD. Nizatidine is indicated for up to 8 weeks for the treatment of active benign gastric ulcer. Before initiating therapy, care should be taken to exclude the possibility of malignant gastric ulceration.